42
Views
4
CrossRef citations to date
0
Altmetric
Expert Opinion

The role of glatiramer acetate in the early treatment of multiple sclerosis

Pages 329-336 | Published online: 09 Jun 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alessandra Lugaresi. (2013) RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence . Expert Opinion on Drug Delivery 10:2, pages 273-283.
Read now

Articles from other publishers (3)

Lydia Asrat Haile, Swamy Kumar Polumuri, Roshni Rao, Logan Kelley-Baker, Dimitri Kryndushkin, Rajesh Rajaiah, Tomer Israely, V. Ashutosh Rao & Daniela Verthelyi. (2017) Cell based assay identifies TLR2 and TLR4 stimulating impurities in Interferon beta. Scientific Reports 7:1.
Crossref
Bianca Weinstock-Guttman, Kavita V. Nair, Joseph L. Glajch, Tanmoy C. Ganguly & Daniel Kantor. (2017) Two decades of glatiramer acetate: From initial discovery to the current development of generics. Journal of the Neurological Sciences 376, pages 255-259.
Crossref
Wenjun Zhu, Emma E. Frost, Farhana Begum, Parvez Vora, Kelvin Au, Yuewen Gong, Brian MacNeil, Prakash Pillai & Mike Namaka. (2012) The role of dorsal root ganglia activation and brain-derived neurotrophic factor in multiple sclerosis. Journal of Cellular and Molecular Medicine 16:8, pages 1856-1865.
Crossref